Coxsackievirus counters the host innate immune response by blocking type III interferon expression

Journal of General Virology

Volumn 97, Issue 6, 2016, Pages 1368-1380

  Lind, Katharina ^a   Svedin, Emma ^a   Domsgen, Erna ^a   Kapell, Sebastian ^a   Laitinen, Olli H ^a,b   Moll, Markus ^a   Flodström Tullberg, Malin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON TYPE 3; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEINASE; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; IFIH1 PROTEIN, HUMAN; IL29 PROTEIN, HUMAN; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; INTERLEUKIN DERIVATIVE; PICORNAIN 2A, PICORNAVIRUS; TLR3 PROTEIN, HUMAN; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS INFECTION; ENDOSOME; ENTEROVIRUS; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PATHOGENICITY;

CYSTEINE ENDOPEPTIDASES; ENTEROVIRUS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON-INDUCED HELICASE, IFIH1; INTERLEUKINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; VIRAL PROTEINS;

EID: 84976478739     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000443     Document Type: Article

References (45)

1. Andrejeva, J., Childs, K. S., Young, D. F., Carlos, T. S., Stock, N., Goodbourn, S. & Randall, R. E. (2004). The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101, 17264-17269.
2. Barral, P. M., Morrison, J. M., Drahos, J., Gupta, P., Sarkar, D., Fisher, P. B. & Racaniello, V. R. (2007). MDA-5 is cleaved in poliovirus- infected cells. J Virol 81, 3677-3684.
3. Chapman, N. M. & Kim, K. S. (2008). Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 323, 275-292.
4. Dauletbaev, N., Cammisano, M., Herscovitch, K. & Lands, L. C. (2015). Stimulation of the RIG-I/MAVS pathway by polyinosinic: acid upregulates IFN-β in airway epithelial cells with minimal costimulation of IL-8. J Immunol 195, 2829-2841.
5. de Weerd, N. A. & Nguyen, T. (2012). The interferons and their receptors- distribution and regulation. Immunol Cell Biol 90, 483-491.
6. Díaz-San Segundo, F., Weiss, M., Perez-Martín, E., Koster, M. J., Zhu, J., Grubman, M. J. & de los Santos, T. (2011). Antiviral activity of bovine type III interferon against foot-and-mouth disease virus. Arch Virol 413, 283-292.
7. Ding, Q., Huang, B., Lu, J., Liu, Y. J. & Zhong, J. (2012). Hepatitis C virus NS3/4A protease blocks IL-28 production. Eur J Immunol 42, 2374-2382.
8. Drahos, J. & Racaniello, V. R. (2009). Cleavage of IPS-1 in cells infected with human rhinovirus. J Virol 83, 11581-11587.
9. Egli, A., Santer, D. M., O’Shea, D., Tyrrell, D. L. & Houghton, M. (2014). The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg Microbes Infect 3, e51.
10. Feng, Q., Langereis, M. A., Lork, M., Nguyen, M., Hato, S. V., Lanke, K., Emdad, L., Bhoopathi, P., Fisher, P. B. & other authors (2014a). Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 88, 3369-3378.
11. Feng, Q., Langereis, M. A. & van Kuppeveld, F. J. (2014b). Induction and suppression of innate antiviral responses by picornaviruses. Cytokine Growth Factor Rev 25, 577-585.
12. Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M. S. & Colonna, M. (2006). Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 103, 8459-8464.
13. Hermant, P. & Michiels, T. (2014). Interferon-l in the context of viral infections: production, response and therapeutic implications. J Innate Immun 6, 563-574.
14. Hoffmann, H. H., Schneider, W. M. & Rice, C. M. (2015). Interferons and viruses: an evolutionary arms race of molecular interactions. Mod Trends Immunol 36, 124-138.
15. Huber, S. (2008). Host immune responses to coxsackievirus B3. Curr Top Microbiol Immunol 323, 199-221.
16. Hühn, M. H., Hultcrantz, M., Lind, K., Ljunggren, H. G., Malmberg, K. J. & Flodström-Tullberg, M. (2008). IFN-gamma production dominates the early human natural killer cell response to Coxsackievirus infection. Cell Microbiol 10, 426-436.
17. Hühn, M. H., McCartney, S. A., Lind, K., Svedin, E., Colonna, M. & Flodström-Tullberg, M. (2010). Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after coxsackievirus infection. Virology 401, 42-48.
18. Jensen, S. & Thomsen, A. R. (2012). Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol 86, 2900-2910.
19. Joachims, M., Van Breugel, P. C. & Lloyd, R. E. (1999). Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 73, 718-727.
20. Knip, M. & Simell, O. (2012). Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med 2, a007690.
21. Kotenko, S. V. (2011). IFN-λs. Curr Opin Immunol 23, 583-590.
22. Kräusslich, H. G., Nicklin, M. J., Toyoda, H., Etchison, D. & Wimmer, E. (1987). Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol 61, 2711-2718.
23. Lazear, H. M., Nice, T. J. & Diamond, M. S. (2015). Interferon-λ: immune functions at barrier surfaces and beyond. Immunity 43, 15-28.
24. Lei, X., Sun, Z., Liu, X., Jin, Q., He, B. & Wang, J. (2011). Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol 85, 8811-8818.
25. Li, M., Liu, X., Zhou, Y. & Su, S. B. (2009). Interferon-λ: the modulators of antivirus, antitumor, and immune responses. J Leukoc Biol 86, 23-32.
26. Lin, R., Mamane, Y. & Hiscott, J. (1999). Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol 19, 2465-2474.
27. Lind, K., Hühn, M. H. & Flodström-Tullberg, M. (2012). Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes. Clin Exp Immunol 168, 30-38.
28. Lind, K., Richardson, S. J., Leete, P., Morgan, N. G., Korsgren, O. & Flodström-Tullberg, M. (2013). Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets. J Virol 87, 7646-7654.
29. Lind, K., Svedin, E., Utorova, R., Stone, V. M. & Flodström-Tullberg, M. (2014). Type III interferons are expressed by coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection. Clin Exp Immunol 177, 687-695.
30. Liu, S., Cai, X., Wu, J., Cong, Q., Chen, X., Li, T., Du, F., Ren, J., Wu, Y. T. & other authors (2015). Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630.
31. Mukherjee, A., Morosky, S. A., Delorme-Axford, E., Dybdahl-Sissoko, N., Oberste, M. S., Wang, T. & Coyne, C. B. (2011). The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7, e1001311.
32. Negishi, H., Osawa, T., Ogami, K., Ouyang, X., Sakaguchi, S., Koshiba, R., Yanai, H., Seko, Y., Shitara, H. & other authors (2008). A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci U S A 105, 20446-20451.
33. Pallansch, M. A. & Roos, R. P. (2007). Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Fields Virology, 5th edn, pp. 839-893. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus. Philadelphia, PA: Lippincott Williams & Wilkins.
34. Pott, J., Mahlakõiv, T., Mordstein, M., Duerr, C. U., Michiels, T., Stockinger, S., Staeheli, P. & Hornef, M. W. (2011). IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 108, 7944-7949.
35. Rebsamen, M., Meylan, E., Curran, J. & Tschopp, J. (2008). The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ 15, 1804-1811.
36. Richardson, S. J., Leete, P., Dhayal, S., Russell, M. A., Oikarinen, M., Laiho, J. E., Svedin, E., Lind, K., Rosenling, T., Morgan, N. G. & other authors (2014). Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia 57, 392-401.
37. Servant, M. J., ten Oever, B., LePage, C., Conti, L., Gessani, S., Julkunen, I., Lin, R. & Hiscott, J. (2001). Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J Biol Chem 276, 355-363.
38. Stetson, D. B. & Medzhitov, R. (2006). Type I interferons in host defense. Immunity 25, 373-381.
39. Taylor, K. E. & Mossman, K. L. (2013). Recent advances in understanding viral evasion of type I interferon. Immunology 138, 190-197.
40. Wang, D., Fang, L., Liu, L., Zhong, H., Chen, Q., Luo, R., Liu, X., Zhang, Z., Chen, H. & Xiao, S. (2011). Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-λ1 pathway. Mol Immunol 49, 407-412.
41. pro targets MAVS to inhibit antiviral type I interferon responses. PLoS Pathog 9, e1003231.
42. Wang, Y., Li, J., Wang, X., Ye, L., Zhou, Y., Thomas, R. M. & Ho, W. (2014). Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line. Innate Immun 20, 3-11.
43. White, J. P., Cardenas, A. M., Marissen, W. E. & Lloyd, R. E. (2007). Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe 2, 295-305.
44. Xiang, Z., Li, L., Lei, X., Zhou, H., Zhou, Z., He, B. & Wang, J. (2014). Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J Virol 88, 6650-6659.
45. Yeung, W. C., Rawlinson, W. D. & Craig, M. E. (2011). Enterovirus infection and type 1 diabetes mellitus: systematic review and metaanalysis of observational molecular studies. BMJ 342, d35.